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The realization of injury to large motor neurons is embedded within contextual reference to the parallel pathways of apoptosis
and necrosis of system-patterned evolution. A widespread loss of cell components occurs intracellularly and involves a reactive
participation to a neuroinflammation that potentially is immunologically definable. In such terms, sporadic and hereditary forms
of amyotrophic sclerosis are paralleled by the components of a reactive nature that involve the aggregation of proteins and
conformational misfolding on the one hand and a powerful oxidative degradation that overwhelms the proteasome clearance
mechanisms. In such terms, global participation is only one aspect of a disorder realization that induces the development of the
defining systems of modulation and of injury that involves the systems of consequence as demonstrated by the overwhelming
immaturity of the molecular variants of mutated superoxide dismutase. It is further to such processes of neuroinflammatory
consequence that the immune system is integral to the reactive involvement of neurons as patterns of disease recognition and
as the system biology of prevalent voluntarily motor character. It is highly significant to recognize various inflammatory states
in the nervous system as prototype variability in phenotype expression and as incremental progression in pathogenesis. In fact
a determining definition of amyotrophic lateral sclerosis is an incremental phenotype modulation within the pathways of the
consequential loss and depletion of motor cell components in the first instance. Neuroinflammation proves a pattern of the
contextual spread of such pathogenic progression in the realization of end-stage injury states involving neurons and neuronal
networks.
1. Introduction
Amyotrophic lateral sclerosis (ALS) is manifested by an array
of the large neuronal cell loss of motor type as further
constituted by a toxic gain of the function of superoxide
dismutase in a small percentage of the patients. The evolu-
tionary course of the disease is further constituted by a series
of progressive changes that aﬀect clinically both sporadic
and hereditary forms of motor neuronal loss [1]. In such
manner, composite manifestations attest to a widespread
semblance to neuronal trophic factor deficiency that is
superimposed by a constitutive dying back phenomenon of
axonal degeneration in the virtual absence of sensory nerve
involvement.
2. Disease Pattern
Disease pattern is recognizable in terms of ongoing changes
in neuronal cells that comprises a noncell autonomous
involvement implicating glial cells ranging from astrocytic
glutamate production and microglial reactivity. Nuclear
factor-kappaB downregulation in neuronal nuclei in ALS
might promote the loss of neuroprotection or else be
associated with nuclear loss [2].
The developmental consequences of injury in this dis-
order are further evidenced by the appearance of defects in
axonal transport and in the phosphorylation of light and
heavy forms of neurofilament, by the appearance of aggrega-
tion or inclusion bodies and also by such structures as hyaline
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bodies consisting of mutant superoxide dismutase, skein
inclusions, Bunina bodies, and at times discrepancy in the
evolutionary course when correlated with specific missense
mutations of superoxide dismutase gene.
The overall dynamics of this heterogeneous group of
disorders complicate a derivational body of consequences
that results, in the overwhelming majority of cases, in re-
spiratory failure after some 2-3 years of disease course.
The skeletal muscle atrophy is a realization of the central
nervous system involvement that evolves as an apparent
consequence to lesions in motor supplying neuronal axons
and to abnormalities in eventual neuromuscular junctions
supplying these muscles. Disease-driven changes in ATP-
binding cassette drug eﬄux transporters in the CNS interfere
with eﬀective ALS pharmacotherapies [3].
A network basis for the disease is recognizable in terms
of evolutionary dynamics in the face of injury to a systemic
series of structural components throughout the entire com-
plex of motor neuronal supply to skeletal muscle. In such
manner, patterns of involvement are realized dimensions
of network participation in the delineation of progressive
kinetics in skeletal muscle atrophy.
The disease recognition patterns of involvement are
reflected in the systemic response of neurons to endoplasmic
reticulum stress and cytosol saturation bymutant superoxide
dismutase in some 20% of the hereditary cases of amy-
otrophic lateral sclerosis. In such manner, oxidative stress is
a recognized component pathway with indices referable to
such stress response to a primary injury to neurons. It is
in such capacity of attempted containment of the cellular
stress that the progression of this disorder proves the true
dimensional dynamics of pathogenesis in neuronal cell loss.
Oligoclonal bands in the CSF of patients with ALS may be
associated with gene mutations [4]. Further participation of
other anti-oxidants also feature in a series of response path-
ways that correlate with the production of such molecules as
free oxygen radicals and peroxynitrite in a mode of systemic
involvement involving cell signalling pathways and deranged
intracellular transport mechanics. A central issue is the glob-
ality of posttranslational modifications of neurofilaments
and an oxidative burst of induced neuronal apoptosis and
necrosis. The overall parameters of the induced performance
and further execution of oxidative stress and injury are
integral components of derived consequence in the injury
response of neurons to intracellular stress.
Microglia become transformed and neurotoxic in end-
stage disease ALS [5].
Aggregation of immature forms of superoxide dismutase
and the mechanics of cytosol-nuclear abnormalities of the
exchange and transport of antioxidants also are referable to
the dimensions of a recognition pattern signature of disease
involvement that attests to the overall dynamics of neuronal
cell death pathways [6].
Lipid and DNA oxidation correlate with the systems of
the aggregation of inclusion bodies as further attested by the
oxidation of the superoxide dismutase itself. It is further to
ongoing developmental outlines of disease reappraisal that
amyotrophic lateral sclerosis is indeed a response pattern
of consequence within the contextual reproducible pathways
of ongoing aberrant intracellular transport mechanics. Neu-
roinflammation proves a response to neuronal dysfunction
and death and response manipulation might alter disease
progression [7]. An essential aspect of participating influence
in the ongoing progression of amyotrophic lateral sclerosis is
the potentially inflammatory array of constitutive factors in
pathogenesis that are allied to the system forms of involve-
ment as in central nervous system involvement in AIDS
patients and in multiple sclerosis victims.
3. Dynamics of Neuroinflammation in General
The concept of the renewal of the immune response arises
in terms of a recurring system of parallel pathways that may
especially target the central nervous system.
It is with regard to an extensive repertoire of conditioning
and reconditioning manoeuvres that the overall dimension-
ality of targeting provokes a reappraisal of current processes
that prove dominant in further injuring the brain in patients
with acquired immunodeficiency syndrome [8]. A critical
array of parallel and superimposed parameters proves deci-
sive in determining a series of abnormal system responses on
the part of the central nervous system itself. The increased
chemotactic signals in HIV infection of the brain promote
a marked transmigration into the CNS [9]. In such modes
of participation, the integral involvement of both the innate
and adaptive systems of immune response proves paramount
determinant in providing an excessive or deficient overall
response that operatively compromises the systems of the
conditioning multifocality of tissue [10]. It is within the
conceptual integrity of the multiple diﬀerent cell and tissue
components of the brain that the realization of injury is
potentially protected by a diversity of immune response and
is also further provoked by the dimensions of inflammation
that exceed dynamic targeting capability. Interferon-gamma
signalling and proinflammatory eﬀect injure oligodendro-
cytes in multiple sclerosis [11]. Metabotropic glutamate
receptors modulate glial cell proliferation, glutamate uptake,
neurotrophic support, and neuroinflammation [12].
It is further to be realized that the systems of the involve-
ment of inflammatory reactivity are borne out by a system
organ that is participant in provoking systemic by-products
as defined by multiple organs such as the reactive spleen and
lymph nodes.
Such panorama of participating components in AIDS
encephalitis is a truly derived phenomenon and also a real
originator of further aberrant responsiveness as evidenced
by a wide diversity of possible opportunistic infections seen
clinically in patients with AIDS.
It is within the developmentally aberrant severity of the
inflammatory response within the central nervous system
that the realization of tissue injury proves a progressive
phenomenon of self-sustaining participation in injuring
further the native neural tissues [13]. The significance of
the realization of a focus of encephalitis or cerebritis is the
concurrent process of integrative evolution in the further
establishment of the parameters of incremental progression
even in a generic sense. Monocyte turnover and mono-
cyte/macrophage activation are implicated in progression in
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HIV encephalitis [14]. This is also evidenced in patients
suﬀering from recurrent attacks of multiple sclerosis within
the scope of developmental outcome in system involvement
as evidenced by oligodendrocyte depletion and the loss of
myelin sheaths [15].
B cells and antibodies are implicated in at least a subset
of patients with multiple sclerosis and are related to the pro-
duction of oligoclonal bands. The CNS also locally produces
antibodies [16].
The extreme variability of pathologic events both in
patients with AIDS encephalitis and also in patients with
diﬀerent biologic substrate in evolving multiple sclerosis
proves a serial representation of multimodal realizations that
provoke an immune participation that results in a further
augment in the inflammatory response. Lipid metabolism
and vascular pathology are both implicated in multiple
sclerosis [17].
In such manner, the provocation of a targeting inflam-
matory process is determined and also determines in its turn
an alternating but self-sustaining realization of tissue injury
that spans the dimensional conditions in AIDS encephalitis
or multiple sclerosis. It is further to a serial reconstruction
of various forms of injury to neural tissues that the by-
product of significant injury is the main criteria in the
evidential proposition of inflammatory and immune system
induction to further tissue injury [18]. Oxidative stress may
target mitochondria and induce both neurodegeneration and
demyelination [19].
The distinctive cell subpopulations of the involvement of
the central nervous system are real component of a confined
series of pathways of an organ such as the brain that
proves not immune privileged [20]. Thus, paradoxically,
the participant organ system is a realization of the ongoing
cooperative participation of the immune and inflammatory
responses. A large body of evidence implicates autoimmunity
in multiple sclerosis [21]. It is further to system integrity
that the overall eﬀects of AIDS encephalitis and the recurrent
relapses of multiple sclerosis both prove a highly persistent
form of active tissue injury in terms specifically of the tissue
component identities of the central nervous system [22].
The realization of an injury to neural tissues is a significant
dimension of the reproducible persistence of the disease
process. Mechanisms of the pleiotropic eﬀects of sodium
channels involve interactions between glia and neurons via
cytokines, growth factors, and neurotransmitters at synapses
and axons [23]. The provocative further promotion of injury
to tissues is represented or constituted by such systems as
astrocytic and microglial response and as plaque enlarge-
ment and demyelination.
The constitutive evidence for a further increment in dis-
ease activity is borne out by developmental innate immune
response and as further signified by the injury to multiple
tissue components [24].
The multifocality of injury to the CNS is an integration
of evidential pathways of the reconstruction of the injurious
events themselves in various modes of the further promotion
of such pathways as directed microglial response and as
participating vascularity and as also gliosis and subsequent
aberrant immune- and inflammatory-mediated responses
[25]. HIV treatment failure allows the compartmentalized
viral replication and development of resistance [26].
Further to the significant emergence of tissue injury, the
parameters of dimensional involvement in CNS inflamma-
tion are dramatically reconstituted in terms of the realization
of new, targeted responses to other foci of directed involve-
ment. It is significant to consider the overall dimensions of
realization in terms of the participation of the overall self-
augmenting or positive feedback loops in CNS inflammatory
states [27].
Dual participation of the immune and the inflammatory
pathways proves integrative, especially with an increasing
severity of these responses towards further foci of neural
injury. The dimensions of further cooperative participation
are mutually self-identifying motives in the significant
emergence to necrotic foci of neural tissue.
Microglia express various Pattern Recognition Recep-
tors to identify viral signatures called Pathogen Associated
Molecular Patterns to which microglia respond by producing
inflammatory mediators [28].
In terms of such ongoing pathway culmination, the per-
sistence of an integrative response is paradoxically self-
generating as realized also by the intermittent relapses in
multiple sclerosis patients or in the recurrent attacks of
opportunistic infection in AIDS patients.
4. Neuroinflammation in Motor Neuronal Loss
Neuroinflammation is a potentially constitutive mode of
pathogenesis in various neurodegenerative disorders such
as amyotrophic lateral sclerosis that evolves as an apparent
primary neuronal cell loss within the additional contexts
of the parallel evolution of apoptosis and necrosis of the
neurons [29].
In such manner, a beneficial incremental change attests
to the possible limitation of injury that is partly contributed
to by glial cells such as astrocytes and by microglial reactivity.
The corresponding pathologic spread in amyotrophic
lateral sclerosis of a putative agent is analogous to dynamics
of involvement in prion disease in terms of aggregation that
corresponds to mechanics of neuronal cell loss in these
disorders.
The innate immune response is a recognized compo-
nent pattern of involvement in a disease process such as
neurodegeneration whereby also inclusion bodies are the
consequences of attested intracellular stress mechanics.
Disease recognition patterns as network involvement
primarily indicate system participation in pathogenic pro-
gression and also as incremental definition of inflammatory
pathways. In such terms, the distribution of motor neuron
loss indicates a predilection for neurons in reference to such
indices as the large size of the cells and as further spread
involvement within the neuronal motor systems [30].
Toxic gain of function of mutant superoxide dismutase
indicates a realization that is deferentially distributed due
to modes of action independent of enzymatic function. In
such manner, the promotional realization of evidential
pathways includes derived neuronal lesions that arise as
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neuroinflammatory foci and as distributional realization for
the further spread of the neuronal cell loss.
Composite idealization is dimensionally ensured as a
significant pattern formulation in disease signature defini-
tion. It is in view of comparable indices as parameters of
evolution that disease progression permits and also enhances
susceptibility to stress-induced injury to individual neurons
within motor system pathways.
Blood brain barrier breakdown leads to a neuroinflam-
mation and oxidative stress [31].
Distributional markers as models of injury indicate a
proximate series of changes that account in turn for the
oxidative series of modulated lesions within the patterns of
the evolutionary progression of the disease.
Hereditary motor neuronal lesions prove a susceptibility
series of a heightened nature and are formulated by the
network reactivity of neuronal subsets.
System biology is a source of potential realization in
amyotrophic lateral sclerosis that persistently constitutes the
determined involvement of systems of the progression of a
disease process that is rapid and incrementally realized as a
loss of large motor neurons. It is further to such considera-
tions that the outline parameters of overall index involve-
ment include the definition of patterns of disease definition
within the distributional reality of the motor neuronal
system as a whole.
The overactivity parameters of oxidative stress somehow
include a toxic gain of function that involves systems of
repair or compensation, on the one hand, and also serial
modulation of recoverability as system dimensions of the
disease entity.
It is in terms of such evolutionary course that the further
outline of lesion characterization permits the distribution of
significant lesions beyond simple oxidative stress.
The sporadic form of amyotrophic lateral sclerosis in-
cludes oxidative stress in its own right but as definable
beyond mutations of the superoxide dismutase enzyme. It
is with regard to further neuroinflammatory injury that
the immune system appears as a common referential series
of pathways in its own right that defines the nature of
characterized neuronal cell loss.
Neuroinflammation pathogenically links such diverse
conditions such as amyotrophic lateral sclerosis, AIDS en-
cephalitis, and multiple sclerosis with the marked activation
of astrocytes and microglia and the production of proin-
flammatory agonists. Upregulation of endothelial adhesion
molecules and downgrading of tight junction proteins
facilitate in particular CNS the ingress of T lymphocytes [32].
In such manner, parametric indices allow for the emer-
gence of overall dimensions as important determinants in the
characterization of the progressive course of a disorder that
is primarily depletive but also reactive. Neuroinflammation,
hence, is constitutionally a superimposed series of gains in
toxicity that overcome recoverability parameters on the part
of individual neurons as integrated signature networks of
pattern recognition.
Significant overall dimensions of inclusion allow for the
distribution of lesions within the intracellular compartment
in modes of aggregation and precipitation as evidenced
by forms of mutated superoxide dismutase that lack in
particular the Zn ion or of the disulfide bonds.
It is further to a compromising realization of immature
metabolic phenotype that mitochondrial damage precipi-
tates apoptotic cell death and also other metabolic phe-
notypes of the realized destabilization of the proteasomal
system in misfolded protein clearance.
With reference to misfolded moieties of protein aggre-
gation it is significant to recognize the reactive constitution
of the motor system disorders within the context of further
progression of the neuronal cell loss.
5. Concluding Remarks
Various aspects of the biology of neuronal cell loss permit
the global evolution of injury that complicates patterns of
potential recoverability in the face of evolutionary system
participation. Allowance for participation is significant in
terms of furthermodulation of the lesion that accommodates
indices of determining pathogenic influence. Neuroinflam-
mation is a powerfully eﬀective series of revision pathways
that incorporate the subsequent realization of the evolution-
ary patterns of an incremental nature.
In terms of serial conformation and as evidential system
patterns, the biology of amyotrophic lateral sclerosis consists
of an inflammatory reactivity in the face of the serial
reconstitution of inflammatory and immune pathways that
incrementally challenge the neuronal viability issues.
Such processes implicate the significant modification of
phenotype as evidential systems of systemic requirement. It
is with regard to system pathways that the conclusive phen-
omenon of neuronal cell death indicates the deliberate
termination of system determination.
In overall terms, the required pathogenic course dynam-
ics in neuronal cell loss participate as systems of over-
riding reactivity. Significant signature recognition patterns
of pathogenic progression are potentially implicated in
amyotrophic lateral sclerosis.
Such incremental indices would indicate the overwhelm-
ing systemic central nervous system involvement as predom-
inant neuroinflammatory indices of activity and reactivity.
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